Tag: Canakinumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Canakinumab

EPS for Novartis AG (NVS) forecasted at $1.31

Added to Collection on: 2018-12-24 22:48:45

Tags for this article:

Business
Health
Biotechnology
New York Stock Exchange
Novartis
Seeking Alpha
Tilray
NVS
Canakinumab

Click the tags to see associated articles and topics

View Article Details
Novartis bets $1.6B on a biotech's anti-inflammatory drugs

Added to Collection on: 2019-04-01 00:07:30

Tags for this article:

Bristol-Myers Squibb
Novartis
Atlas Venture
Industries
Life Sciences
Medication
Canakinumab

Click the tags to see associated articles and topics

View Article Details
JPM: Novartis CMO Tsai on how the pandemic is changing the face of biopharma R&D, how ...

Added to Collection on: 2021-01-12 12:56:15

Tags for this article:

Life Sciences
Pharmaceutical companies
Health sciences
Novartis
Canakinumab
Hydroxychloroquine
John Tsai

Click the tags to see associated articles and topics

View Article Details
Canakinumab Plus Chemotherapy Show No OS Improvement in Advanced or Metastatic NSCLC

Added to Collection on: 2021-03-09 21:33:45

Tags for this article:

Cancer treatments
Clinical medicine
Medicine
Lung cancer
Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Canakinumab
Pembrolizumab
Non-small-cell lung carcinoma
Adjuvant therapy
Novartis

Click the tags to see associated articles and topics

View Article Details
AZ's proposed acquisition of rare disease-focused Alexion gets US clearance

Added to Collection on: 2021-04-20 14:37:30

Tags for this article:

Companies
Life Sciences
Health sciences
Orphan drugs
Alexion Pharmaceuticals
AstraZeneca
Immunosuppressants
Eculizumab
Ravulizumab
Novartis
Canakinumab

Click the tags to see associated articles and topics

View Article Details
Novartis says it overpaid Roche's Genentech nearly $210 million in a licensing deal—and it wants ...

Added to Collection on: 2021-06-28 15:56:15

Tags for this article:

Companies
Life Sciences
Industry economics)
Novartis
Genentech
Canakinumab
Chiron Corporation
Secukinumab

Click the tags to see associated articles and topics

View Article Details
Arthritis drug does NOT increase survival rates of patients hospitalized with severe COVID-19 ...

Added to Collection on: 2021-07-20 15:00:00

Tags for this article:

Health sciences
Medicine
Health
Clinical research
Drug discovery
Pharmaceutical industry
Design of experiments
Monoclonal antibodies
COVID-19 drug development
Canakinumab
Placebo
Clinical trial

Click the tags to see associated articles and topics

View Article Details
Effect of Canakinumab on Survival Outcomes Without Invasive Mechanical Ventilation in ...

Added to Collection on: 2021-09-02 15:22:30

Tags for this article:

Clinical research
Medicine
Health sciences
Health
Canakinumab
Clinical trials
Organofluorides
Placebo-controlled study
Placebo
Dexamethasone

Click the tags to see associated articles and topics

View Article Details
CANOPY-1 Data Support Continued Study of Canakinumab in Select Populations of ...

Added to Collection on: 2021-10-28 18:25:58

Tags for this article:

Cancer treatments
Clinical medicine
Drugs
Antineoplastic drugs
Lung cancer
Canakinumab
Breakthrough therapy
Orphan drugs
Pembrolizumab
Non-small-cell lung carcinoma
Interleukin 1 beta
Novartis

Click the tags to see associated articles and topics

View Article Details
A pharma insider and a music maven launch a health care VC - STAT News

Added to Collection on: 2022-10-26 11:35:20

Tags for this article:

Pharmaceutical companies
Companies
Ronald Burkle
D. A. Wallach
Novartis
Industries
Canakinumab
Regulus Therapeutics
Del Mar
Wallach
Tim Wright
A. Wallach

Click the tags to see associated articles and topics

View Article Details